Medisafe Adherence App: What the Evidence Says About Its Real Impact 

Poor medication adherence is estimated to contribute to around 125,000 deaths and $290 billion in avoidable healthcare costs every year in the US alone. The Medisafe adherence app tries to close that gap with personalised reminders, a nurse hotline for missed doses, and a peer community – and the early independent evidence, while still limited, is genuinely encouraging usability and engagement. This article explains how the app works, why adherence is such a large problem, and what two small studies found. 

Key takeaways 

• Poor adherence is estimated to cause 125,000 deaths and $290 billion in avoidable US healthcare costs a year – the scale that apps like Medisafe are trying to address. 

• Medisafe uses machine learning to personalise reminders rather than sending every patient at the same generic prompt. 

• Independent studies are still small, but patients rate the app highly on usability: 93% said reminders helped them take medication on time. 

• Beyond the patient experience, adherence data is a genuine opportunity for pharma brands – if it’s used as an input into support programmes, not left sitting in a dashboard. 

What Is the Medisafe Adherence App, and How Does It Work? 

The Medisafe adherence app is a mobile platform, originally built as a medication reminder, that now functions as a broader patient engagement tool for people managing chronic conditions. It has partnered with pharmaceutical companies and uses machine learning to personalise the experience for each user, rather than sending everyone the same generic prompt at the same time every day. The app sends patients reminders to take their medicine, and connects users who have missed too many doses to a nurse’s hotline for extra support. For patients facing financial constraints, it can incorporate copay cards from patient assistance programmes directly into the experience, and when a patient reports a side effect, it connects them to a community of users going through the same thing. 

Why Does Medication Adherence Matter This Much? 

In the US alone, poor medication adherence is estimated to contribute to around 125,000 deaths and $290 billion in avoidable healthcare costs every year¹. The same behaviours that drive that toll – forgetting a dose, misunderstanding a regimen, or simply losing motivation to keep going – show up in chronic disease management across Asia-Pacific’s ageing populations too, which is why the region has its own, fast-growing market for adherence apps. 

How Does Medisafe Try to Change Adherence Behaviour? 

Medisafe’s roots explain its design choices. The app began in 2012, after brothers Omri and Rotem Shor watched their father accidentally take a double dose of insulin – a mistake that could easily have been fatal, and one they realised almost any patient managing multiple medications could make just as easily. What started as a simple pill-reminder has since scaled into a patient engagement platform used by roughly 13 million patients across more than 150 countries⁴. 

A 2024 narrative review of mobile medication-adherence apps used across Asia found that the features patients engaged with most closely mirror what Medisafe has already built in: straightforward reminders, the ability to loop in a family member or peer community, and support available in a patient’s own language, rather than a generic, one-size-fits-all design⁵. That matters for a region where mobile penetration is extremely high, chronic disease prevalence is rising quickly, and family involvement in day-to-day care decisions is often the norm rather than the exception. 

Does the Medisafe Adherence App Work? What the Evidence Shows 

The independent evidence is still thin, but what exists is encouraging usability and engagement specifically, rather than proof of long-term adherence gains. 

• Case 1: A small preliminary study at a US clinic. Ten medically underserved patients with chronic conditions used the app for two weeks at a federally qualified health centre; researchers recorded a statistically significant increase in patients’ confidence in managing their own medication regimen, alongside a smaller, non-significant improvement in self-reported adherence². 

• Case 2: A larger usability and satisfaction survey. A follow-up survey, again among medically underserved patients, found the app scored well on the things that predict continued use: every participant said they would recommend it to family or friends, 93% said its reminders helped them take medication on time, and 90% found it easy to use³. These remain small, single-site studies rather than large randomised trials. 

Want to turn adherence data into a genuine patient support advantage? DeltaMV’s Healthcare Behavioural Strategy team helps pharmaceutical and healthcare organisations design the behavioural strategy that sits behind programmes like this. 

How to Use Adherence App Data in a Patient Support Programme: 3 Steps 

1. Treat adherence data as a behavioural signal, not just a compliance metric. Look at when and why patients disengage, not only whether they take a dose. 

2. Design the human escalation path before launching. The nurse hotline for missed doses is what turns a reminder app into a support programme – plan who responds and how, not just the notification itself. 

3. Built in community and family features deliberately. The Asia review found this matter more than generic reminders alone, especially where family involvement in care decisions is the norm. 

What Are the Limitations of the Evidence So Far? 

• Independent evidence is still limited to small, single-site studies – not large randomised trials. 

• Usability and engagement scores are strong, but they aren’t the same as proven long-term adherence or outcome gains. 

• Much of the available evidence is on self-reported adherence and confidence, which can overstate real-world behaviour change. 

Frequently Asked Questions 

Does the Medisafe adherence app actually improve medication adherence? 

Early independent studies show strong usability and engagement scores, with a signal of improved confidence in managing medication – but the evidence base is still small, so it’s not yet proof of large-scale adherence gains. 

What makes Medisafe different from a basic pill reminder? 

Machine-learning personalisation, a nurse hotline for missed doses, copay-card integration, and a peer community for side-effect support. 

How can pharma brands use Medisafe-style adherence data? 

As an input into patient support programmes and messaging – tracking when and why patients disengage, not just whether they logged a dose. 

Is adherence app data useful in Asia-Pacific specifically? 

Yes. A 2024 regional review found the features patients in Asia engage with most – reminders, family involvement, and local-language support – are already core to how these apps are designed⁵. 

Next Steps: Turn Adherence Data Into a Genuine Patient Support Advantage 

The strategic question for pharma brands isn’t whether to have a presence in this space, but how to use adherence data responsibly and effectively – as a genuine input into patient support programmes and messaging, rather than another data set that sits unused in a dashboard. 

Ready to translate adherence and engagement data into interventions that actually change behaviour? Get in touch with DeltaMV’s Healthcare Behavioural Strategy team. 

Sources 

1. American Pharmacists Association Foundation. (2014). A dose of reality: Medication non-adherence causes 125,000 deaths, $290 billion in healthcare costs annually [Press release]. PR Newswire. https://www.prnewswire.com/news-releases/a-dose-of-reality-medication-non-adherence-causes-125000-deaths-290-billion-in-healthcare-costs-annually-278381621.html 

2. Hartch, C. E., Dietrich, M., & Stolldorf, D. (2023). Effect of a medication adherence mobile phone app on medically underserved patients with chronic illness: Preliminary efficacy study. JMIR Formative Research, 7, e50579. https://doi.org/10.2196/50579 

3. Hartch, C. E., Dietrich, M., Lancaster, B., Mulvaney, S. A., & Stolldorf, D. P. (2025). Satisfaction and usability of a commercially available medication adherence app (Medisafe) among medically underserved patients with chronic illnesses: Survey study. JMIR Human Factors, 12, e63653. https://doi.org/10.2196/63653 

4. Medisafe. (2025). The genesis of Medisafe. https://www.medisafe.com/the-genesis-of-medisafe/ 

5. Wang, T., Huang, Y.-M., & Chan, H.-Y. (2024). Exploration of features of mobile applications for medication adherence in Asia: Narrative review. Journal of Medical Internet Research, 26, e60787. https://doi.org/10.2196/60787